EPI-111

N/A

Report date: 2023/08/07 17:46:46

Base Information

Drug NameEPI-111
Drug Alias NameEPI-111
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionU4/U6 small nuclear ribonucleoprotein Prp31 gene transference
TargetsU4/U6 small nuclear ribonucleoprotein Prp31
Therapy Area/IndicationsRetinitis Pigmentosa
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEpicrispr Biotechnologies Inc
China Registration ClassN/A

Develop Information

Active CompaniesEpicrispr Biotechnologies Inc
Inactive CompaniesN/A
Active IndicationsRetinitis Pigmentosa
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A